EUVIMEDEUVIMED entdecken
Crossref

Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma

Quanyou Wu iD, Chunfang Hu, Lin Feng, Xin Yang, Ying Cui, Huan Zhao, Ting Xiao, Huiqin Guo

Cancer · 2024

DOI: 10.1002/cncr.35517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Quanyou Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Cancer, Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hosp…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Cancer, Papillary, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infiltrative follicular variant of papillary thyroid carcinoma (IFVPTC) exhibits nuclear characteristics typical of papillary thyroid carcinoma (PTC) but demonstrates a follicular growth pattern. The diagnosis of IFVPTC presenting with atypical nuclear features of PTC poses challenges for both preoperative cytopathology and postoperative histopathology. In such cases, molecular markers are needed to serve as diagnostic aids. Given the limited knowledge of IFVPTC's genomic features, this study aimed to characterize its genetic alterations and identify clinically relevant molecular markers.

Methods

Whole‐exome sequencing of 50 IFVPTC tumor–normal pairs identified single‐nucleotide variants, somatic copy number alterations (sCNAs), and subclonal architecture. Key mutations were verified via polymerase chain reaction and Sanger sequencing, whereas valuable biomarkers were validated via immunohistochemistry (IHC).

Results

This study found that endogenous processes rather than exogenous mutagens dominated the shaping of the genome of IFVPTC during tumorigenesis. BRAF V600E was the only common trunk mutation and significantly mutated gene in IFVPTC. Subcloning analysis found that most IFVPTC samples harbored two or more coexisting clones. sCNA analysis revealed that human leukocyte antigen C (HLA‐C) and HLA‐A were significantly amplified. Subsequent IHC investigations indicated that HLA‐C shows promise in averting the misclassification of challenging‐to‐interpret IFVPTC and invasive encapsulated follicular variant of PTC (I‐EFVPTC) as noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP). Although there were several similarities between classic PTC and IFVPTC, they differed significantly in their sCNA patterns.

Conclusions

This study provides valuable insights into IFVPTC's genetic alterations and highlights the potential of HLA‐C IHC to distinguish challenging‐to‐interpret IFVPTC and I‐EFVPTC from NIFTP, which will enhance the understanding of its molecular features for improved diagnosis and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid Cancer, PapillaryMutationHumansMaleFemaleMiddle AgedAdultExome SequencingBiomarkers, TumorCarcinoma, Papillary, FollicularProto-Oncogene Proteins B-rafDNA Copy Number VariationsAgedGenomics

Stichwörter der Autor:innen

diagnosisgenetic alterationsinfiltrative follicular variant of papillary thyroid carcinomasubclonal architecturewhole‐exome sequencing

Substanzen

Biomarkers, TumorBRAF protein, humanProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • Division of Abdominal Cancer, Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, China.
  • State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking…
  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Hebei Cancer Hospital, Chinese Academy of Medical Sciences, Langfang, China.

ORCID-Profile: Quanyou Wu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, Q., Hu, C., Feng, L., Yang, X., Cui, Y., Zhao, H., Xiao, T., & Guo, H. (2024). Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma. Cancer. https://doi.org/10.1002/cncr.35517

Vancouver

Wu Q, Hu C, Feng L, Yang X, Cui Y, Zhao H, et al. Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma. Cancer. 2024. doi:10.1002/cncr.35517

BibTeX
@article{Wu2024,
  author = {Wu, Quanyou and Hu, Chunfang and Feng, Lin and Yang, Xin and Cui, Ying and Zhao, Huan and Xiao, Ting and Guo, Huiqin},
  title = {Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35517}
}
Kostenlos starten →